Mutant feline sarcoma proviruses containing the viral oncogene (v-fes) and either feline or murine control elements.
about
Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequencesMultiple enhancer domains in the 3' terminus of the Prague strain of Rous sarcoma virus.Tissue tropism of a leukemogenic murine retrovirus is determined by sequences outside of the long terminal repeatsActivated Ki-Ras complements erythropoietin signaling in CTLL-2 cells, inducing tyrosine phosphorylation of a 160-kDa protein.Nucleotide sequence of the feline retroviral oncogene v-fms shows unexpected homology with oncogenes encoding tyrosine-specific protein kinases.Transforming potential of a human protooncogene (c-fps/fes) locus.The long terminal repeat of an endogenous intracisternal A-particle gene functions as a promoter when introduced into eucaryotic cells by transfection.A recessive cellular mutation in v-fes-transformed mink cells restores contact inhibition and anchorage-dependent growth.A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene.Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes.Contribution of the gag and pol sequences to the leukemogenicity of Friend murine leukemia virus.At least four viral genes contribute to the leukemogenicity of murine retrovirus MCF 247 in AKR miceCharacterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus.The envelope gene and long terminal repeat sequences contribute to the pathogenic phenotype of helper-independent Friend virusesFlat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes.
P2860
Q24645275-850BC0DB-3A1C-4C36-93A1-27C909C85033Q35438722-DB833AF6-76D6-41F6-B668-F959CD671AFDQ35605627-F966353E-533E-46CA-9A6B-03C41EA8EC5EQ35751753-F627BB54-705A-40CA-9AD2-B7A889754A07Q36244780-C2D88E75-10E2-43C8-8BCA-B731A92216B2Q36260822-B4D7A9AE-6A2F-4CBC-B5A6-9D7140DD3C80Q36587114-D21374BC-0609-46E4-B9A8-DE23AC44C24FQ36790213-05AFF804-4359-4338-810B-7D6A2F709291Q36832497-4C73A87A-9E4F-44A7-A423-E7B4591D0B71Q36888532-F2DF9272-3744-4762-9FD1-0362D95CE745Q36902274-FF801BCD-8110-4BB0-9C58-A96341A3D1D5Q36903997-85E0B73A-D6FE-48CD-96AB-B37B76EDADFDQ36910993-23D4364A-D287-4CD2-BA08-77821728EDE6Q36918996-EF3F7447-4047-4932-8363-93EC590210D6Q37348891-FF368DC9-F84B-4A20-810D-D048207357F6
P2860
Mutant feline sarcoma proviruses containing the viral oncogene (v-fes) and either feline or murine control elements.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Mutant feline sarcoma provirus ...... ne or murine control elements.
@en
type
label
Mutant feline sarcoma provirus ...... ne or murine control elements.
@en
prefLabel
Mutant feline sarcoma provirus ...... ne or murine control elements.
@en
P2093
P2860
P1433
P1476
Mutant feline sarcoma provirus ...... ine or murine control elements
@en
P2093
Anderson SJ
Galibert F
P2860
P304
P407
P577
1983-03-01T00:00:00Z